PSA nadir and time to PSA nadir during initial androgen deprivation therapy as prognostic factors in metastatic castration‐resistance prostate cancer patients treated with docetaxel-Reference-Cited by-同舟云学术

PSA nadir and time to PSA nadir during initial androgen deprivation therapy as prognostic factors in metastatic castration‐resistance prostate cancer patients treated with docetaxel

Published:2021-02-16 Issue:4 Volume:53 Page:
ISSN:0303-4569
Container-title:Andrologia
language:en
Short-container-title:Andrologia

Author:

Shi Xinyu¹^ORCID,Pei Xinqi¹,Fan Junjie¹²,Liu Tianjie¹,Zhang Dize¹,Yang Tao¹,Wu Kaijie¹,He Dalin¹,Li Lei¹

Affiliation:

1. Department of Urology First Affiliated Hospital of Xi'an Jiaotong University Xi'an China

2. Department of Urology Baoji Center Hospital Baoji China

Publisher

Wiley

Subject

Urology,Endocrinology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/and.13916

Reference31 articles.

1. Prostate‐specific antigen decline pattern in advanced prostate cancer receiving androgen deprivation therapy and relationship with prostate‐specific antigen progression;Akbay E.;Aging Male,2017

2. Management of patients with advanced prostate cancer in the Asia Pacific region: ‘real-world’ consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017

3. The incidence, mortality, and risk factors of prostate cancer in Asian men

4. Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality

5. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis;Frontiers in Oncology;2023-02-09

2. PSA nadir and time to PSA nadir during initial androgen deprivation therapy as prognostic factors in metastatic castration‐resistance prostate cancer patients treated with docetaxel;Andrologia;2021-02-16

3. Nomogram Incorporating Contrast-Enhanced Ultrasonography Predicting Time to the Development of Castration-Resistant Prostate Cancer;Clinical Medicine Insights: Oncology;2021-01